Item Type | Name |
Concept
|
Combined Modality Therapy
|
Concept
|
Drug Therapy
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Salvage Therapy
|
Concept
|
Treatment Outcome
|
Concept
|
Laser Therapy
|
Concept
|
Molecular Targeted Therapy
|
Concept
|
X-Ray Therapy
|
Concept
|
Treatment Failure
|
Concept
|
Genetic Therapy
|
Concept
|
Organ Sparing Treatments
|
Concept
|
Neoadjuvant Therapy
|
Academic Article
|
Treatment and prognosis of orbital non-Hodgkin's lymphomas.
|
Academic Article
|
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
|
Academic Article
|
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
|
Academic Article
|
Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
|
Academic Article
|
Radiation oncology.
|
Academic Article
|
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
|
Academic Article
|
Head and neck cancer.
|
Academic Article
|
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
|
Academic Article
|
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
|
Academic Article
|
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.
|
Academic Article
|
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.
|
Academic Article
|
Growth factors alter the therapeutic ratio in radiotherapy.
|
Academic Article
|
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation.
|
Academic Article
|
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
|
Academic Article
|
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
|
Academic Article
|
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors.
|
Academic Article
|
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
|
Academic Article
|
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
|
Academic Article
|
The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.
|
Academic Article
|
Functional imaging in treatment planning of brain lesions.
|
Academic Article
|
Increased injection number enhances adenoviral genetic radiotherapy.
|
Academic Article
|
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
|
Academic Article
|
Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
|
Academic Article
|
Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.
|
Academic Article
|
Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors.
|
Academic Article
|
Combined effects of angiostatin and ionizing radiation in antitumour therapy.
|
Academic Article
|
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
|
Academic Article
|
Strategies for enhancing viral-based gene therapy using ionizing radiation.
|
Academic Article
|
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
|
Academic Article
|
Gene therapy of cancer.
|
Academic Article
|
Genetically engineered HSV in the treatment of glioma: a review.
|
Academic Article
|
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors.
|
Academic Article
|
Radiation oncology and the new biology.
|
Academic Article
|
Role of gene therapy in radiation oncology.
|
Academic Article
|
Temporal bone chemodectomas--comparing surgery and radiation therapy.
|
Academic Article
|
Nasopharyngeal carcinoma.
|
Academic Article
|
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
|
Academic Article
|
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
|
Academic Article
|
Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors.
|
Academic Article
|
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
|
Academic Article
|
Radiation-inducible gene therapy.
|
Academic Article
|
Volumetric visualization of head and neck CT data for treatment planning.
|
Academic Article
|
Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
|
Academic Article
|
Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation.
|
Academic Article
|
Molecular targeting of gene therapy and radiotherapy.
|
Academic Article
|
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Radioresistant derivatives of radiosensitive CHO cells obtained following treatment with 5-azacytidine retain their sensitivity to cisplatin.
|
Academic Article
|
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
|
Academic Article
|
PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention.
|
Academic Article
|
Gene therapy enhances the antiproliferative effect of radiation in intimal hyperplasia.
|
Academic Article
|
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
|
Academic Article
|
TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene.
|
Academic Article
|
Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation.
|
Academic Article
|
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.
|
Academic Article
|
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
|
Academic Article
|
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
|
Academic Article
|
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin.
|
Academic Article
|
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
|
Academic Article
|
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
|
Academic Article
|
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma.
|
Academic Article
|
Palliative radiotherapy.
|
Academic Article
|
Chemotherapeutic and biologic radiation enhancement.
|
Academic Article
|
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
|
Academic Article
|
Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
|
Academic Article
|
Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice.
|
Academic Article
|
Transcriptional control of viral gene therapy by cisplatin.
|
Academic Article
|
Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
|
Academic Article
|
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
|
Academic Article
|
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review).
|
Academic Article
|
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.
|
Academic Article
|
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
|
Academic Article
|
Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making.
|
Academic Article
|
Radiotherapy with concomitant chemotherapy for head and neck cancer.
|
Academic Article
|
Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology.
|
Academic Article
|
Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo.
|
Academic Article
|
Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
|
Academic Article
|
Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).
|
Academic Article
|
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
|
Academic Article
|
Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay.
|
Academic Article
|
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
|
Academic Article
|
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.
|
Academic Article
|
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
|
Academic Article
|
Ionizing radiation: a genetic switch for cancer therapy.
|
Academic Article
|
Gene therapy: the challenges of translating laboratory research into clinical practice.
|
Academic Article
|
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer.
|
Academic Article
|
Radiation or surgery for chemodectoma of the temporal bone: a review of local control and complications.
|
Academic Article
|
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
|
Academic Article
|
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
|
Academic Article
|
Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy.
|
Academic Article
|
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
|
Academic Article
|
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
|
Academic Article
|
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003.
|
Academic Article
|
Recent advances in radiation therapy for head and neck cancer.
|
Academic Article
|
More on cetuximab in head and neck cancer.
|
Academic Article
|
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiforme.
|
Academic Article
|
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.
|
Academic Article
|
Enhancing radiotherapy with genetically engineered viruses.
|
Academic Article
|
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
|
Academic Article
|
Multidisciplinary treatment for childhood sarcoma.
|
Academic Article
|
A rationale for the targeted treatment of oligometastases with radiotherapy.
|
Academic Article
|
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
|
Academic Article
|
Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
|
Academic Article
|
Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia.
|
Academic Article
|
Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
|
Academic Article
|
Chemo-inducible gene therapy.
|
Academic Article
|
Importance of local control in an era of systemic therapy.
|
Academic Article
|
Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers.
|
Academic Article
|
Characterization of response to radiation mediated gene therapy by means of multimodality imaging.
|
Academic Article
|
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
|
Academic Article
|
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
|
Academic Article
|
MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.
|
Academic Article
|
How does antiangiogenic therapy affect brain tumor response to radiation?
|
Academic Article
|
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
|
Academic Article
|
Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.
|
Academic Article
|
Breast conserving surgery and definitive irradiation for early stage breast cancer.
|
Academic Article
|
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
|
Academic Article
|
Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors.
|
Academic Article
|
A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer.
|
Academic Article
|
Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1.
|
Academic Article
|
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
|
Academic Article
|
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
|
Academic Article
|
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.
|
Academic Article
|
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
|
Academic Article
|
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
|
Academic Article
|
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.
|
Academic Article
|
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.
|
Academic Article
|
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone.
|
Academic Article
|
A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects.
|
Academic Article
|
Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas.
|
Academic Article
|
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease.
|
Academic Article
|
Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results.
|
Academic Article
|
Cytogenetic observations of a human ovarian carcinoma clinically resistant to therapy.
|
Academic Article
|
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease.
|
Academic Article
|
Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.
|
Academic Article
|
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
|
Academic Article
|
The influence of initial pathologic stage on the survival of patients who relapse from Hodgkin's disease.
|
Academic Article
|
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
|
Academic Article
|
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
|
Academic Article
|
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
|
Academic Article
|
Multidisciplinary treatment of advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.
|
Academic Article
|
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.
|
Academic Article
|
Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy.
|
Academic Article
|
The role of radiotherapy in locally advanced pancreatic carcinoma.
|
Academic Article
|
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
|
Academic Article
|
Management of stage I and II Hodgkin's disease.
|
Academic Article
|
Substaging of stage III Hodgkin's disease.
|
Academic Article
|
Treatment selection in T1 and T2 vocal cord carcinoma.
|
Academic Article
|
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
|
Academic Article
|
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
|
Academic Article
|
Preliminary results of aggressive multimodality therapy for metastatic osteosarcoma.
|
Academic Article
|
Superficial doses in treatment of breast with tangential fields using 4MV x-rays.
|
Academic Article
|
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.
|
Academic Article
|
Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiation.
|
Academic Article
|
Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
|
Academic Article
|
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
|
Academic Article
|
Radiation therapy in the management of patients with mesothelioma.
|
Academic Article
|
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer.
|
Academic Article
|
Improved survival time trends for glioblastoma using the SEER 17 population-based registries.
|
Academic Article
|
Development of additional primary tumors after 62 years in the first patient with retinoblastoma cured by radiation therapy.
|
Academic Article
|
Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
|
Academic Article
|
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
|
Academic Article
|
Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner.
|
Academic Article
|
The role of paclitaxel in the treatment of head and neck cancer.
|
Academic Article
|
Chemical modulation of the hypoxic fraction in the treatment of head and neck cancer.
|
Academic Article
|
Radiobiologic research for head and neck cancer therapy. Therapeutic implications.
|
Academic Article
|
Measurable impact: multimodality therapy of head and neck cancer.
|
Academic Article
|
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results.
|
Academic Article
|
Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo.
|
Academic Article
|
Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.
|
Academic Article
|
The role of radiation therapy in the treatment of soft tissue sarcomas of childhood.
|
Academic Article
|
Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response.
|
Academic Article
|
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
|
Academic Article
|
Surgical management of the head and neck cancer patient following concomitant multimodality therapy.
|
Academic Article
|
Radiation therapy in head and neck cancer: indications and limitations.
|
Academic Article
|
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy.
|
Academic Article
|
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate.
|
Academic Article
|
Chemotherapy for advanced carcinoma of the head and neck. A clinical update.
|
Academic Article
|
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.
|
Academic Article
|
Spatial and temporal control of gene therapy using ionizing radiation.
|
Academic Article
|
Timing and sequencing of chemoradiotherapy.
|
Academic Article
|
Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.
|
Academic Article
|
Gene therapy targeted by ionizing radiation.
|
Academic Article
|
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.
|
Academic Article
|
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy.
|
Academic Article
|
Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role.
|
Academic Article
|
Chemotherapy of advanced salivary gland neoplasms.
|
Academic Article
|
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.
|
Academic Article
|
Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide.
|
Academic Article
|
Combined modality therapy of head and neck cancer.
|
Academic Article
|
Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer.
|
Academic Article
|
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus.
|
Academic Article
|
Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results.
|
Academic Article
|
Swallowing function in patients with head and neck cancer prior to treatment.
|
Academic Article
|
Antitumor interaction of short-course endostatin and ionizing radiation.
|
Academic Article
|
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
|
Academic Article
|
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
|
Academic Article
|
Tumor production of angiostatin is enhanced after exposure to TNF-alpha.
|
Academic Article
|
Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
|
Academic Article
|
gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.
|
Academic Article
|
ReVOLT: radiation-enhanced viral oncolytic therapy.
|
Academic Article
|
Outcomes in black patients with early breast cancer treated with breast conservation therapy.
|
Academic Article
|
A downside to apoptosis in cancer therapy?
|
Academic Article
|
Radiation therapy for non-Hodgkin's lymphoma.
|
Academic Article
|
Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.
|
Academic Article
|
Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer.
|
Academic Article
|
Small cell carcinomas of the larynx: results of combined modality treatments.
|
Academic Article
|
The evolution of combination therapy of genitourinary rhabdomyosarcoma in children: a preliminary report.
|
Academic Article
|
The role of post-operative radiation therapy in the treatment of malignant tumors of the parotid gland.
|
Academic Article
|
Radiation therapy in the treatment of aggressive fibromatoses.
|
Academic Article
|
Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems.
|
Academic Article
|
The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.
|
Academic Article
|
Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.
|
Academic Article
|
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
|
Academic Article
|
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
|
Academic Article
|
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
|
Academic Article
|
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeā¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
|
Academic Article
|
A survivin-associated adaptive response in radiation therapy.
|
Academic Article
|
Stereotactic body radiation therapy for curative treatment of adrenal metastases.
|
Academic Article
|
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.
|
Academic Article
|
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy.
|
Academic Article
|
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
|
Academic Article
|
Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis.
|
Academic Article
|
Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
|
Academic Article
|
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
|
Academic Article
|
Race and competing mortality in advanced head and neck cancer.
|
Academic Article
|
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
|
Academic Article
|
Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma.
|
Academic Article
|
Effect of postradiotherapy neck dissection on nonregional disease sites.
|
Academic Article
|
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.
|
Academic Article
|
Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
|
Academic Article
|
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.
|
Academic Article
|
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.
|
Academic Article
|
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy.
|
Academic Article
|
Stereotactic radiotherapy for pulmonary metastases.
|
Academic Article
|
Racial parities in outcomes after radiotherapy for head and neck cancer.
|
Academic Article
|
Optimizing management of colorectal hepatic metastases: now and in the future.
|
Academic Article
|
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
|
Academic Article
|
Nanomedicine for Combination Therapy of Cancer.
|
Academic Article
|
From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy.
|
Academic Article
|
Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
|
Academic Article
|
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
|
Academic Article
|
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).
|
Academic Article
|
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy.
|
Academic Article
|
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs.
|
Academic Article
|
Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
|
Academic Article
|
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
|
Academic Article
|
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.
|
Academic Article
|
Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.
|
Academic Article
|
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.
|
Academic Article
|
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
|
Academic Article
|
Radiotherapy and immunotherapy: a beneficial liaison?
|
Academic Article
|
Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast Cancer.
|
Academic Article
|
InĀ Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases.
|
Academic Article
|
Survival outcomes for postoperative chemoradiation in intermediate-risk oral tongue cancers.
|
Academic Article
|
Nanoscale Metal-Organic Frameworks for Therapeutic, Imaging, and Sensing Applications.
|
Academic Article
|
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers.
|
Academic Article
|
Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.
|
Academic Article
|
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
|
Academic Article
|
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma.
|
Academic Article
|
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.
|
Academic Article
|
Oxygen-Guided Radiation Therapy.
|
Academic Article
|
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy.
|
Academic Article
|
The 46th David A. Karnofsky Memorial Award Lecture: Oligometastasis-From Conception to Treatment.
|
Academic Article
|
Oligometastatic prostate cancer: Reality or figment of imagination?
|
Academic Article
|
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
|
Academic Article
|
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-?B and p53 Codependent Manner in Glioblastoma.
|
Academic Article
|
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
|
Academic Article
|
Beyond Palliation: The Rationale for Metastasis-Directed Therapy for Metastatic Non-Small Cell Lung Cancer.
|
Academic Article
|
Integration of radiotherapy and immunotherapy for treatment of oligometastases.
|
Academic Article
|
Tumor-reprogrammed resident T cells resist radiation to control tumors.
|
Academic Article
|
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
|
Academic Article
|
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer.
|
Academic Article
|
DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-?B and sensitize to alkylating chemotherapy.
|
Academic Article
|
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research.
|
Academic Article
|
Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable.
|
Academic Article
|
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
|
Academic Article
|
Response Letter: Radiation therapy for COVID-19 pneumopathy.
|
Academic Article
|
Coronavirus Disease 2019 Infection Prevention and Control Practices in Wuhan Radiation Therapy.
|
Academic Article
|
Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy.
|
Academic Article
|
Ultrathin metal-organic layer-mediated radiotherapy-radiodynamic therapy enhances immunotherapy of metastatic cancers.
|
Academic Article
|
Oligometastasis: Past, Present, Future.
|
Academic Article
|
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
|
Academic Article
|
The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.
|
Academic Article
|
Small Animal IMRT Using 3D-Printed Compensators.
|
Academic Article
|
Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors.
|
Academic Article
|
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus.
|
Academic Article
|
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
|
Academic Article
|
Prospective Clinical Investigation of the Efficacy of Combination Radiation Therapy With Immune Checkpoint Inhibition.
|
Academic Article
|
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold.
|
Academic Article
|
Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression.
|
Academic Article
|
Radiotherapy and immunotherapy: open questions and future strategies.
|
Academic Article
|
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget Radiotherapy.
|
Academic Article
|
Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
|
Academic Article
|
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy.
|
Academic Article
|
The oligometastatic spectrum in the era of improved detection and modern systemic therapy.
|
Academic Article
|
Author Correction: Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
|
Academic Article
|
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade.
|
Academic Article
|
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.
|
Concept
|
Proton Therapy
|
Academic Article
|
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
|
Academic Article
|
Nanoscale coordination polymer synergizes photodynamic therapy and toll-like receptor activation for enhanced antigen presentation and antitumor immunity.
|
Academic Article
|
Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models.
|
Academic Article
|
Nanoscale Covalent Organic Framework with Staggered Stacking of Phthalocyanines for Mitochondria-Targeted Photodynamic Therapy.
|
Academic Article
|
Corrigendum: Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models.
|
Academic Article
|
RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy.
|
Academic Article
|
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal.
|
Academic Article
|
Simultaneous Protonation and Metalation of a Porphyrin Covalent Organic Framework Enhance Photodynamic Therapy.
|
Academic Article
|
Radiotherapy, immunity, and immune checkpoint inhibitors.
|
Academic Article
|
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.
|
Academic Article
|
Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer Treatment.
|